-
Tech names drag down world stocks, oil dips on supply hopes
-
Starmer vows 'orderly' transition as Labour MPs mull bid to be PM
-
Reports of Dupont inclusion in France squad 'bordering on annoying' says Galthie
-
ACTIVIST SHAREHOLDER FILES SCHEDULE 13D IN EQUUS TOTAL RETURN, INC.
-
England coach McCullum denies rift with 'good friend' Stokes
-
Europe: the world's fastest-warming continent
-
Taliban officials hold EU migration talks in Brussels
-
Gennaro Gattuso returns to coaching with Lazio after Italy debacle
-
Kenya halts US Ebola facility: health minister tells court
-
Why the heat is wreaking havoc on Europe's trains
-
Zelensky to skip key Ukraine conference in Poland over WWII row
-
Seoul leads rout for tech shares as oil prices dip
-
Europe heatwave closes schools, threatens health
-
India monsoon sweeps north but brings less rain than usual
-
Germany eyes longer working lives in pension reform plan
-
UK and markets await Burnham's economic plans
-
Iran says won't allow UN inspectors at bombed nuclear sites
-
Heineken names new CEO after predecessor's shock departure
-
Banned Vondrousova insists she has 'never doped'
-
Schools plan to close as UK braces for record-breaking heatwave
-
UN chief urges AI firms to 'come clean' over environmental footprint
-
India startup head Kunal Shah appointed as new WhatsApp boss
-
More records set to fall as deadly Europe heatwave drags on
-
Israel's 'deliberate targeting' of children part of ongoing Gaza 'genocide': UN probe
-
England, Ghana eye last 32 as Portugal look for lift-off
-
Seoul's Kospi stock index tanks 10% to lead tech-fuelled Asia rout
-
Sri Lanka troops to battle deadly dengue mosquitoes as cases rise
-
Iran says to oversee Hormuz as Swiss talks conclude
-
Diaspora World Cup champions diversity over division
-
Guns, drones and doves: War reshapes Ukrainian jewellery scene
-
Australia withholds Pacific climate fund reports over risk of diplomatic 'damage'
-
Kenya police violence victims say compensation promise a 'smokescreen'
-
Indian startup head appointed as new WhatsApp boss
-
EU bets on digital euro to cut US tech addiction
-
Antetokounmpo joining Miami Heat in blockbuster: reports
-
Fineanganofo rethinks Newcastle move after All Blacks call-up
-
'Let's be realistic': Haaland cools Norway's World Cup expectations
-
Stocks fluctuate after Wall St sell-off, crude holds losses on peace talks
-
Lightning, downpour, a two-hour delay: bad weather hits the World Cup
-
Ultra-reclusive Turkmenistan slowly opens up to tourists
-
Two-goal Haaland fires Norway into World Cup last 32
-
Marc Bloch, historian and Resistance hero, joins France's Pantheon greats
-
Last one the best one? How Messi keeps doing it at World Cup
-
Ronaldo 'a role model' says Portugal coach after slow World Cup start
-
Savea 'embraces challenge' of leading All Blacks towards World Cup
-
North Korea's Kim vows to accelerate military buildup
-
Savea 'embraces challlenge' of leading All Blacks towards World Cup
-
Latin America's resurgent right notches another win in Colombia
-
Mbappe scores twice as France beat Iraq at World Cup after two-hour storm delay
-
Trump threatens prison for damage to Washington Reflecting Pool
No-prescription birth control pills soon available in US pharmacies
Prescription-free birth control pills will be available across the United States later this month, widening access to contraception at a time when abortion rights have been drastically curtailed.
American-Irish maker Perrigo Company announced Monday that its Opill has "shipped to major retailers and pharmacies and will be available on shelves nationwide," available in one-month and three-month packs for $19.99 and $49.99 respectively. It will also be available on Opill.com.
Over-the-counter (OTC) birth control has long been backed by major medical organizations as a way to reduce barriers to contraception access, with more than 6.1 million births in the US each year unintended, according to official data.
"We champion the right of women and people to determine their own sexual health journey and the availability of Opill over-the-counter is truly a historic moment of which our entire organization can be proud," said Perrigo Executive Vice President Triona Schmelter.
Opill, which was cleared last year by the Food and Drug Administration for sale without prescription, is known as a "mini pill" because it contains progestin only, and works by thickening mucus in the cervix to stop sperm reaching an egg.
Preserving access to contraception has proven politically divisive following the conservative-led Supreme Court's decision to revoke the national right to abortion in 2022.
Twenty-one states banned or moved to restrict abortions to limits tighter than before Roe v Wade, the case law that previously upheld the constitutional right to terminate a pregnancy.
Republicans in Congress also blocked Democrat-backed legislation that would have codified individuals' right to access contraception, an issue that has taken on more urgency as conservative-run states define personhood in new ways.
Alabama's top court last month said that frozen embryos should be considered children, though the state's legislature quickly moved to pass a bill protecting clinics from legal liability if such embryos were inadvertently damaged or destroyed.
Over-the-counter birth control is backed by major medical organizations, including the American College of Obstetricians and Gynecologists (ACOG), the American Medical Association and the American Academy of Family Physicians.
Much of Asia, Africa and Latin America allow OTC birth control. The UK joined the club in 2021, but prescriptions are still required in much of mainland Europe including France, Germany, Spain and Italy, according to "Free the Pill" which tracks the issue.
P.Staeheli--VB